Dynavax Technologies Corporation (DVAX)
NASDAQ: DVAX · IEX Real-Time Price · USD
11.61
+0.13 (1.13%)
At close: Jul 26, 2024, 4:00 PM
11.42
-0.19 (-1.64%)
After-hours: Jul 26, 2024, 7:20 PM EDT
Dynavax Technologies Market Cap
Dynavax Technologies has a market cap or net worth of $1.52 billion as of July 26, 2024. Its market cap has decreased by -13.67% in one year.
Market Cap
1.52B
Enterprise Value
1.05B
1-Year Change
-13.67%
Ranking
Category
Stock Price
$11.61
Market Cap Chart
Since February 19, 2004, Dynavax Technologies's market cap has increased from $222.50M to $1.52B, an increase of 582.99%. That is a compound annual growth rate of 9.85%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 25, 2024 | 1.50B | -16.85% |
Dec 29, 2023 | 1.81B | 33.12% |
Dec 30, 2022 | 1.36B | -19.57% |
Dec 31, 2021 | 1.69B | 244.22% |
Dec 31, 2020 | 490.30M | 2.21% |
Dec 31, 2019 | 479.70M | -16.37% |
Dec 31, 2018 | 573.60M | -49.38% |
Dec 29, 2017 | 1.13B | 644.48% |
Dec 30, 2016 | 152.20M | -83.61% |
Dec 31, 2015 | 928.40M | 109.43% |
Dec 31, 2014 | 443.30M | -13.87% |
Dec 31, 2013 | 514.70M | 1.06% |
Dec 31, 2012 | 509.30M | 20.97% |
Dec 30, 2011 | 421.00M | 13.85% |
Dec 31, 2010 | 369.80M | 531.06% |
Dec 31, 2009 | 58.60M | 74.93% |
Dec 31, 2008 | 33.50M | -83.51% |
Dec 31, 2007 | 203.20M | -41.66% |
Dec 29, 2006 | 348.30M | 177.97% |
Dec 30, 2005 | 125.30M | -36.40% |
Dec 31, 2004 | 197.00M | -11.46% |
Feb 19, 2004 | 222.50M | - |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Brookdale Senior Living | 1.51B |
Belite Bio | 1.49B |
Indivior | 1.48B |
U.S. Physical Therapy | 1.46B |
Nurix Therapeutics | 1.46B |
Sana Biotechnology | 1.39B |
Day One Biopharmaceuticals | 1.39B |
Vir Biotechnology | 1.39B |